Teva Pharmaceuticals USA recalls Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30 count HDPE bottles, Rx Only, Distributed by TEVA PHARMACEUTI
Recalled March 22, 2017 · FDA recall D-0517-2017 · Teva Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications · FDA Class II
Units
7,628 HDPE bottles (228,840 tablets)
Sold at
Nationwide
Description
Failed Impurities/Degradation Specifications
Product
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30 count HDPE bottles, Rx Only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5721-56
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →